Molecular imaging and theragnostics of thyroid cancers
L Giovanella, D Deandreis, A Vrachimis, A Campenni… - Cancers, 2022 - mdpi.com
Simple Summary According to the American Cancer Society, approximately 53,000 new
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …
Update on the diagnosis and management of medullary thyroid cancer: what has changed in recent years?
K Kaliszewski, M Ludwig, B Ludwig, A Mikuła… - Cancers, 2022 - mdpi.com
Simple Summary Medullary thyroid carcinoma (MTC) is a rare neoplasm that is responsible
for a fair proportion of thyroid carcinoma related deaths. The current diagnostic and …
for a fair proportion of thyroid carcinoma related deaths. The current diagnostic and …
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
Abstract Preamble The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an
international scientific and professional organization founded in 1954 to promote the …
international scientific and professional organization founded in 1954 to promote the …
CTR-FAPI PET enables precision management of medullary thyroid carcinoma
Z Kong, Z Li, XY Cui, J Wang, M Xu, Y Liu… - Cancer …, 2025 - aacrjournals.org
Medullary thyroid carcinoma (MTC) can only be cured through the excision of all metastatic
lesions, but current clinical practice fails to localize the disease in 29% to 60% of patients …
lesions, but current clinical practice fails to localize the disease in 29% to 60% of patients …
Nuclear Medicine and Cancer Theragnostics: Basic Concepts
V Zoi, M Giannakopoulou, GA Alexiou, P Bouziotis… - Diagnostics, 2023 - mdpi.com
Cancer theragnostics is a novel approach that combines diagnostic imaging and
radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …
radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …
Advanced imaging and theranostics in thyroid cancer
ME Roseland, YK Dewaraja… - Current Opinion in …, 2022 - journals.lww.com
Advanced imaging and theranostics in thyroid cancer : Current Opinion in Endocrinology,
Diabetes and Obesity Advanced imaging and theranostics in thyroid cancer : Current Opinion …
Diabetes and Obesity Advanced imaging and theranostics in thyroid cancer : Current Opinion …
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Background Somatostatin receptor (SSTR) positron emission tomography/computed
tomography (PET/CT) is increasingly deployed in the diagnostic algorithm of patients …
tomography (PET/CT) is increasingly deployed in the diagnostic algorithm of patients …
Functional imaging in thyroid cancer patients with metastases and therapeutic implications
Functional imaging plays a central role in the management of thyroid cancer patients. In
patients with a differentiated thyroid cancer (DTC), radioactive iodine (RAI) is used mostly …
patients with a differentiated thyroid cancer (DTC), radioactive iodine (RAI) is used mostly …
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives
Purpose Medullary thyroid carcinoma (MTC) originates from thyroid parafollicular C-cells
and represents< 5% of all thyroid cancers. Serum Calcitonin (CTn) is considered the most …
and represents< 5% of all thyroid cancers. Serum Calcitonin (CTn) is considered the most …
Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic …
P Li, Y Zhang, T Xu, J Zhu, T Wei… - Nuclear Medicine …, 2023 - journals.lww.com
Objectives Detecting medullary thyroid carcinoma (MTC) metastatic lesions accurately is still
a challenge for clinicians. PET/computed tomography (PET/CT) seems to be the most …
a challenge for clinicians. PET/computed tomography (PET/CT) seems to be the most …